Search Results - "WILDE, J. T."

The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation by Bolton-Maggs, P. H. B., Perry, D. J., Chalmers, E. A., Parapia, L. A., Wilde, J. T., Williams, M. D., Collins, P. W., Kitchen, S., Dolan, G., Mumford, A. D.

“…The rare coagulation disorders are heritable abnormalities of haemostasis that may present significant difficulties in diagnosis and management. This review…”
Get full text

Deficiency of natural anticoagulant proteins C, S, and antithrombin in portal vein thrombosis: a secondary phenomenon? by Fisher, N C, Wilde, J T, Roper, J, Elias, E

“…BACKGROUND Hereditary deficiencies of natural anticoagulant proteins are implicated in the pathogenesis of portal vein thrombosis (PVT). Secondary deficiencies…”
Get full text

Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis by Mahmoud, A E, Elias, E, Beauchamp, N, Wilde, J T

“…BACKGROUND: The factor V Leiden (FVL) mutation has been shown to be the most frequent cause of hereditary thrombophilia. The prevalence of the mutation in…”
Get full text

HIV and HCV coinfection in haemophilia by Wilde, J. T.

“…A substantial number of haemophilic patients are infected with both human immunodeficiency virus (HIV) and hepatitis C (HCV). HIV has been shown to accelerate…”
Get full text

The UK Haemophilia Doctors Organisation triennial audit of UK Comprehensive Care Haemophilia Centres by WILDE, J. T.

“…Under the auspices of the United Kingdom Haemophilia Doctors Organisation (UKHCDO) the UK Comprehensive Care Haemophilia Centres (CCCs) have undergone a three…”
Get full text

A parametric contact model to describe the interlocking of soft bodies with ridged surface textures used in haptic applications by Wilde, T.J., Schwartz, C.J.

“…Tactile interactions with product surfaces are essential to how such products are used and the value that users ascribe to them. It has been shown that contact…”
Get full text

Protease inhibitor therapy and bleeding by Wilde, J T

“…Shortly after the introduction of protease inhibitor drugs (PIs) for the treatment of human immunodeficiency virus infection an association between these drugs…”
Get full text

Elective surgery on factor VIII inhibitor patients using continuous infusion of recombinant activated factor VII: plasma factor VII activity of 10 IU/ml is associated with an increased incidence of bleeding by Smith, M P, Ludlam, C A, Collins, P W, Hay, C R, Wilde, J T, Grigeri, A, Melsen, T, Savidge, G F

“…We examined recombinant activated factor VII (rVIIa) administered by continuous infusion to eight patients with inhibitors to factor VIII, undergoing elective…”
Get more information

Increased bleeding associated with protease inhibitor therapy in HIV‐positive patients with bleeding disorders by Wilde, Jonathan T., Lee, Christine A., Collins, Peter, Giangrande, Paul L. F., Winter, Mark, Shiach, Caroline R.

“…The use of protease inhibitor (PI) drugs in treatment regimens for HIV‐infected patients with hereditary bleeding disorders has been associated with an…”
Get full text

Epidemiology of Infection with Epstein-Barr Virus Types 1 and 2: Lessons from the Study of a T-Cell-Immunocompromised Hemophilic Cohort by Yao, Q. Y., Croom-Carter, D. S. G., Tierney, R. J., Habeshaw, G., Wilde, J. T., Hill, F. G. H., Conlon, C., Rickinson, A. B.

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Combined alpha interferon and ribavirin for the treatment of hepatitis C in patients with hereditary bleeding disorders by SHIELDS, P. L, MUTIMER, D. J, MUIR, D, SKIDMORE, S, BRITNELL, T, ROBERTS, A, WILDE, J. T

“…Patients with hereditary bleeding disorders who received non‐virally inactivated plasma‐derived clotting factor concentrates before the mid‐1980s invariably…”
Get full text

Hyperhomocysteinaemia and vascular disease by Townend, J., O'Sullivan, J., Wilde, J.T.

“…The amino-acid homocysteine plays a crucial role in cell metabolism. It participates in the remethylation pathway enabling maintenance of adequate cellular…”
Get full text

Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven®] in elective orthopaedic surgery in haemophilic patients with inhibitors by GIANGRANDE, P. L. F., WILDE, J. T., MADAN, B., LUDLAM, C. A., TUDDENHAM, E. G. D., GODDARD, N. J., DOLAN, G., INGERSLEV, J.

“…Patients with haemophilia complicated by inhibitors have a significant burden of joint disease, which is associated with a negative impact on their quality of…”
Get full text

Is it justifiable to transplant infected livers into haemophilia recipients? by Rowe, I. A., Wilde, J. T., Mutimer, D.

Get full text

Relapsing thrombotic thrombocytopenic purpura in association with recurrent pancreatitis by DARYANANI, S, WILDE, J. T

“…We report the case of a 28‐year‐old woman who presented with two episodes of acute pancreatitis 3 years apart both of which were complicated by the development…”
Get full text

The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products by ZAMAN, S. M. A., HILL, F. G. H., PALMER, B., MILLAR, C. M., BONE, A., MOLESWORTH, A. M., CONNOR, N., LEE, C. A., DOLAN, G., WILDE, J. T., GILL, O. N., MAKRIS, M.

“…The risk of variant Creutzfeldt‐Jakob disease (vCJD) from potentially infected plasma products remains unquantified. This risk has been assessed for 787 UK…”
Get full text

Update to UKHCDO guidance on vaccination against hepatitis A and B viruses in patients with inherited coagulation factor deficiencies and von Willebrand disease by Watson, H. G., Wilde, J. T., Dolan, G., Millar, C., Yee, T. T., Makris, M.

Get full text

Increased risk of bleeding with the use of tipranavir boosted with ritonavir in haemophilic patients by ARBUTHNOT, C., WILDE, J. T.

Get full text

Haemophilia 2002: emerging risks of treatment by EVATT, B. L., FARRUGIA, A., SHAPIRO, A. D., WILDE, J. T.

“…Haemophilia care and treatment products have greatly improved over the past 2 decades. Transitions in treatment produced by these changes were accompanied by…”
Get full text

UKHCDO guidelines on the management of HCV in patients with hereditary bleeding disorders 2011 by WILDE, J. T., MUTIMER, D., DOLAN, G., MILLAR, C., WATSON, H. G., YEE, T. T., MAKRIS, M.

“…Chronic HCV infection continues to be of significant clinical importance in patients with hereditary bleeding disorders. This guideline provides information on…”
Get full text